Hourglass Capital, LLC Pfizer Inc Transaction History

Hourglass Capital, LLC

$359 Million
Q3 2024

A detailed history of Hourglass Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Hourglass Capital, LLC holds 279,900 shares of PFE stock, worth $7.48 Million. This represents 2.26% of its overall portfolio holdings.

Number of Shares

279,900

Previous 287,310 2.58%

Holding current value

$7.48 Million

Previous $8.04 Million 0.77%

% of portfolio

2.26%

Previous 2.39%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$27.7 - $31.39 $205,257 - $232,599	-7,410 Reduced 2.58%	279,900 $8.1 Million
Q2 2024 Aug 05, 2024	BUY	$25.26 - $29.6 $145,245 - $170,200	5,750 Added 2.04%	287,310 $8.04 Million
Q1 2024 Apr 26, 2024	BUY	$25.89 - $29.73 $154,045 - $176,893	5,950 Added 2.16%	281,560 $7.81 Million
Q4 2023 Feb 09, 2024	BUY	$26.13 - $33.94 $4.46 Million - $5.79 Million	170,631 Added 162.54%	275,610 $7.93 Million
Q3 2023 Nov 02, 2023	BUY	$32.09 - $37.51 $171,360 - $200,303	5,340 Added 5.36%	104,979 $3.48 Million
Q2 2023 Aug 01, 2023	BUY	$36.12 - $41.79 $1.31 Million - $1.51 Million	36,198 Added 57.06%	99,639 $3.65 Million
Q1 2023 Apr 28, 2023	SELL	$39.39 - $51.28 $1,221 - $1,589	-31 Reduced 0.05%	63,441 $2.59 Million
Q4 2022 Feb 09, 2023	BUY	$41.75 - $54.5 $2,922 - $3,815	70 Added 0.11%	63,472 $3.25 Million
Q3 2022 Nov 07, 2022	BUY	$43.76 - $53.42 $17,504 - $21,368	400 Added 0.63%	63,402 $2.77 Million
Q2 2022 Aug 05, 2022	SELL	$46.53 - $55.17 $930 - $1,103	-20 Reduced 0.03%	63,002 $3.3 Million
Q1 2022 May 04, 2022	SELL	$45.75 - $56.69 $2.42 Million - $3 Million	-52,970 Reduced 45.67%	63,022 $3.26 Million
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $1.12 Million - $1.67 Million	-27,196 Reduced 18.99%	115,992 $6.85 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $776,051 - $996,904	-19,772 Reduced 12.13%	143,188 $6.16 Million
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $128,880 - $146,000	3,589 Added 2.25%	162,960 $6.38 Million
Q1 2021 May 06, 2021	SELL	$33.49 - $37.77 $76,558 - $86,342	-2,286 Reduced 1.41%	159,371 $5.77 Million
Q4 2020 Feb 10, 2021	SELL	$33.47 - $42.56 $610,827 - $776,720	-18,250 Reduced 10.14%	161,657 $5.95 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $116,205 - $136,335	3,660 Added 2.08%	179,907 $6.6 Million
Q2 2020 Aug 11, 2020	BUY	$30.12 - $36.54 $1,114 - $1,351	37 Added 0.02%	176,247 $5.76 Million
Q1 2020 May 07, 2020	SELL	$27.03 - $38.62 $93,307 - $133,316	-3,452 Reduced 1.92%	176,210 $5.75 Million
Q4 2019 Feb 12, 2020	BUY	$32.92 - $37.36 $723,910 - $821,546	21,990 Added 13.95%	179,662 $7.04 Million
Q3 2019 Nov 06, 2019	SELL	$32.49 - $42.13 $334,647 - $433,939	-10,300 Reduced 6.13%	157,672 $5.67 Million
Q2 2019 Aug 12, 2019	BUY	$36.98 - $41.52 $231,124 - $259,500	6,250 Added 3.86%	167,972 $7.28 Million
Q1 2019 May 03, 2019	SELL	$37.5 - $41.2 $40,837 - $44,866	-1,089 Reduced 0.67%	161,722 $6.87 Million
Q4 2018 Feb 08, 2019	BUY	$38.47 - $43.86 $82,402 - $93,948	2,142 Added 1.33%	162,811 $7.11 Million
Q3 2018 Nov 09, 2018	SELL	$34.47 - $41.81 $228,880 - $277,618	-6,640 Reduced 3.97%	160,669 $7.08 Million
Q2 2018 Aug 10, 2018	SELL	$32.98 - $35.16 $395,759 - $421,919	-12,000 Reduced 6.69%	167,309 $6.07 Million
Q1 2018 May 07, 2018	BUY	$31.91 - $37.02 $397,279 - $460,899	12,450 Added 7.46%	179,309 $6.36 Million
Q4 2017 Feb 08, 2018	SELL	$33.26 - $35.29 $20,288 - $21,526	-610 Reduced 0.36%	166,859 $6.04 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $5.19 Million - $5.72 Million	167,469	167,469 $5.98 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hourglass Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hourglass Capital, LLC with notifications on news.

Account

Hourglass Capital, LLC Pfizer Inc Transaction History